Serialized Labeling (51662 1388 1 Serialized Labeling)
Hydralazine Hydrochloride Injection
Product Images NDC 51662-1388
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 51662-1388). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Vial Labeling (51662 1388 1 Vial Labeling)
Hydralazine Hydrochloride Injection is a medication that comes in 1 mL single-dose vials for intramuscular use. The NDC number for this medication is 17478-934-01. This medication is produced by AXA and the package contains information about dosage and administration. The other text appears to be miscellaneous characters and can not be evaluated.*
Adverse Reactions (Adverse Reactions)
How Supplied (How Supplied)
This is a product description for single-dose vials packed in boxes of 10 or 25, with the National Drug Code (NDC) of 17478-934-01 or 17478-934-15, respectively. The volume of each vial is 1 mL.*
Overdosage (Overdosage)
This text provides information about the acute toxicity of a substance. No deaths related to acute poisoning have been reported, and the highest known dose survived by adults through oral administration was 10g. Additionally, the text includes data about the oral LD50 in rats, which was found to be in the range of 173-187 mg/kg.*
Structure (Structure Discription)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
